Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that ...

Australia’s second-largest private hospital operator, Healthscope, is in receivership with ten non-binding offers for ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

TOKYO -- Swiss pharmaceutical giant Roche plans to continue investing in major markets including the U.S. and Japan despite President Donald Trump's order to lower drug prices, CEO Thomas Schinecker ...

Swiss pharma firm Roche could reconsider investing billions of dollars in the US after Trump medication prices..

The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body ...

Swiss pharma company Roche (ROG.SW, RHHBY) is warning that its investment into the US could be at risk due to President Trump ...

Roche has reported overall survival outcomes from a Phase III trial of Perjeta with Herceptin and chemotherapy in early-stage ...

Swiss pharma major Roche (ROG: SIX) has reported updated results from its Phase III STARGLO trial, showing that a ...

A group of advisers to the Food and Drug Administration said Roche Holding AG needs to study its blood cancer treatment in ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.